Blog
126 Articles
mRNA Pancreatic Cancer Vaccine Trial Heading for Phase II
Dr. Vinod Balachandran provides the latest data on the mRNA pancreatic cancer vaccine, now headed to a phase II clinical trial.
Adapting Chemotherapy Regimens for a Better Pancreatic Cancer Outcome
Researchers are comparing chemotherapy regimens for effectiveness before surgery, and whether switching treatments makes a difference.
New Prospective Clinical Study of Blood-Based Early Detection Test
Dr. Rosalie Sears is working with Biological Dynamics to test a new early detection blood assay and platform for pancreatic cancer screening.
Taking a Look At FAK Inhibitors
Dr. Conan Kinsey is looking at how FAK inhibitors can make immunotherapy more effective in combination with chemotherapy.
Comparing Chemotherapy Before with Chemotherapy After Pancreatic Cancer Surgery
Researchers are comparing effectiveness of chemotherapy before surgery (neoadjuvant) with chemotherapy after surgery (adjuvant).
New Potential Early Detection Trial for Type 2 Diabetics
Dr. Anna Bergamaschi explains the new Avantect blood test for the early detection of pancreatic cancer in people with type 2 diabetes.
Using Humor to Face Pancreatic Cancer
Richard Liles has a stage IV pancreatic cancer diagnosis but feels it is very important to keep a sense of humor throughout.
Targeting the Oxidation Pathway to Treat Advanced Pancreatic Cancer
Researchers are testing a new drug that targets the oxidation pathway in order to make standard chemotherapy more effective for stage IV pancreatic cancer.
A Year in Review: 2022 in Research
What progress was made in pancreatic treatment and screening? Learn about the major pancreatic cancer developments of 2022.
Testing a New Immunotherapy Combo in Advanced Pancreatic Cancer
Researchers are testing an approved immunotherapy drug with a new drug that works on T cells to make it more effective for pancreatic cancer.
Forget Stages . . . Set Goals Instead!
After her pancreatic cancer diagnosis, Heather Sanderson set goals: surgery and then getting back to the gym.
Urinary Tract Scans Lead to My Diagnosis
Ellen Robbins has the BRCA2 mutation, and that allowed her to participate in a clinical trial for her pancreatic cancer.
Surveillance Improves Outcomes for High-Risk Patients
Dr. Michael Goggins provides results for the CAPS5 pancreatic cancer surveillance and screening study for patients at high risk.
mRNA Vaccine Shows Promising Results
Dr. Vinod Balachandran is testing an mRNA vaccine for pancreatic cancer using the same technology as COVID vaccines.
Report Highlights Potential of TCR Therapy
Read about the potential of TCR therapy, a technique used with success for one pancreatic cancer patient in a groundbreaking immunotherapy clinical trial.